Clinical trial
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women…
NCT00246597 · Ortho Biotech Products, L.P., Industry · Terminated
Key facts
| NCT number | NCT00246597 |
|---|---|
| Title | A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer |
| Official title | A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Breast Neoplasms, Hemoglobins, Quality of Life, Chemotherapy, Adjuvant |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 37 |
| Start date | Dec 1, 2002 |
| Completion | Jun 1, 2004 |
| First posted | Oct 31, 2005 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: